Form 4: Blueprint Medicines COO Christina Rossi Sells Shares Under 10b5-1 Trading Plan

Christina Rossi, Chief Operating Officer of Blueprint Medicines Corp, sold 2,274 shares of common stock on February 20, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Christina Rossi, the Chief Operating Officer of Blueprint Medicines Corp, sold 2,274 shares of common stock on February 20, 2025.
• The sale was executed under a pre-arranged trading plan adopted on August 27, 2024, in accordance with Rule 10b5-1.
• The shares were sold at an average price of $95.14, with individual transactions ranging from $95.00 to $95.23.
• Following the transaction, Rossi directly owns 64,835 shares of Blueprint Medicines Corp.
• The reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this footnote upon request.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an insider stock sale under a pre-arranged trading plan. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales by company executives are a normal part of corporate governance. The use of a 10b5-1 trading plan allows insiders to sell shares over a period of time, avoiding concerns about trading on inside information.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 trading plan mitigates concerns about insider trading.

Key Dates